$41.7 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 25 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WPZ | WILLIAMS PARTNERS LPlp - public equity | $6,719,000 | -3.0% | 172,732 | 0.0% | 16.09% | -21.9% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $2,588,000 | +28.1% | 524,929 | 0.0% | 6.20% | +3.2% | |
| BPTH | BIO-PATH HOLDINGS INC | $1,379,000 | -5.3% | 3,830,882 | 0.0% | 3.30% | -23.7% | |
| GMOLQ | GENERAL MOLY INC | $1,096,000 | +1.5% | 2,922,831 | 0.0% | 2.62% | -18.2% | |
| MGEN | MIRAGEN THERAPEUTICS INC | $965,000 | -29.3% | 105,465 | 0.0% | 2.31% | -43.0% | |
| APEN | APOLLO ENDOSURGERY INC | $722,000 | -40.7% | 154,301 | 0.0% | 1.73% | -52.2% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $439,000 | -25.2% | 35,714 | 0.0% | 1.05% | -39.7% | |
| PLXP | PLX PHARMA INC | $403,000 | +4.7% | 62,673 | 0.0% | 0.96% | -15.6% | |
| POR | PORTLAND GENERAL ELECTRIC CO | $5,000 | 0.0% | 118 | 0.0% | 0.01% | -20.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4/A | 2024-05-14 |
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-04 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.